Use of white blood cell counts to predict metabolic syndrome in the elderly: a 4 year longitudinal study

References

• Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595–607
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539–53
   PubMed Web of Science ®Google Scholar
• Stone NJ, Bilek S, Rosenbaum S. Recent national cholesterol education program adult treatment panel iii update: adjustments and options. Am J Cardiol 2005;96:53E–9E
   PubMed Web of Science ®Google Scholar
• Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003;52:1799–805
   PubMed Web of Science ®Google Scholar
• Nakanishi N, Yoshida H, Matsuo Y, et al. White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men. Diabetologia 2002;45:42–8
   PubMedGoogle Scholar
• Vozarova B, Weyer C, Lindsay RS, et al. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002;51:455–61
   PubMed Web of Science ®Google Scholar
• Ruggiero C, Metter EJ, Cherubini A, et al. White blood cell count and mortality in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol 2007;49:1841–50
   PubMed Web of Science ®Google Scholar
• Oda E, Kawai R. The prevalence of metabolic syndrome and diabetes increases through the quartiles of white blood cell count in Japanese men and women. Intern Med 2009;48:1127–34
   Google Scholar
• Gkrania-Klotsas E, Ye Z, Cooper AJ, et al. Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies. PloS One 2010;5:e13405
   PubMed Web of Science ®Google Scholar
• Ble A, Palmieri E, Volpato S, et al. White blood cell count is associated with some features of metabolic syndrome in a very old population. Nutr Metab Cardiovasc Dis 2001;11:221–6
   Google Scholar
• Chuo SK, Li JC, Tsai WC, et al. Correlations between white blood cell count and metabolic syndrome in middle-age Taiwanese. Endocr Res 2005;31:39–50
   PubMed Web of Science ®Google Scholar
• Hsieh CH, Pei D, Kuo SW, et al. Correlation between white blood cell count and metabolic syndrome in adolescence. Pediatr Int 2007;49:827–32
   PubMed Web of Science ®Google Scholar
• Lao XQ, Neil Thomas G, Jiang C, et al. White blood cell count and the metabolic syndrome in older Chinese: the Guangzhou Biobank Cohort Study. Atherosclerosis 2008;201:418–24
   PubMed Web of Science ®Google Scholar
• Wu CZ, Lin JD, Li JC, et al. Association between white blood cell count and components of metabolic syndrome. Pediatr Int 2009;51:14–18
   PubMed Web of Science ®Google Scholar
• Chen W, Srinivasan SR, Xu J, Berenson GS. Black-white divergence in the relation of white blood cell count to metabolic syndrome in preadolescents, adolescents, and young adults: the Bogalusa Heart Study. Diabetes Care 2010;33:2474–6
   PubMed Web of Science ®Google Scholar
• Wu CZ, Hsiao FC, Lin JD, et al. Relationship between white blood cell count and components of metabolic syndrome among young adolescents. Acta Diabetol 2010;47:65–71
   PubMed Web of Science ®Google Scholar
• Twig G, Afek A, Shamiss A, et al. White blood cell count and the risk for coronary artery disease in young adults. PloS One 2012;7:e47183
   PubMed Web of Science ®Google Scholar
• Odagiri K, Uehara A, Mizuta I, et al. Longitudinal study on white blood cell count and the incidence of metabolic syndrome. Intern Med 2011;50:2491–8
   PubMedGoogle Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–5
   PubMed Web of Science ®Google Scholar
• Department of Health, Executive Yuan, R.O.C. (Taiwan). Available from: http://www.doh.gov.tw/CHT2006/DM/DM2_p01.aspx?class_no=25&now_fod_list_no=5912&level_no=2&doc_no=22602 [last accessed 10 Feb 2013]
   Google Scholar
• Ishizaka N, Ishizaka Y, Toda E, et al. Association between cigarette smoking, white blood cell count, and metabolic syndrome as defined by the Japanese criteria. Intern Med 2007;46:1167–70
   PubMedGoogle Scholar
• Fadini GP, Marcuzzo G, Marescotti MC, et al. Elevated white blood cell count is associated with prevalence and development of the metabolic syndrome and its components in the general population. Acta Diabetol 2012;49:445–51
   PubMed Web of Science ®Google Scholar
• Freeman DJ, Norrie J, Caslake MJ, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002;51:1596–600
   PubMed Web of Science ®Google Scholar
• Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. J Am Med Assoc 2001;286:327–34
   PubMed Web of Science ®Google Scholar
• Kim JA, Park HS. White blood cell count and abdominal fat distribution in female obese adolescents. Metabolism 2008;57:1375–9
   PubMed Web of Science ®Google Scholar
• Twig G, Afek A, Shamiss A, et al. White blood cells count and incidence of type 2 diabetes in young men. Diabetes Care 2013;36:276–82
   PubMedGoogle Scholar
• Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 2010;17:332–41
   PubMed Web of Science ®Google Scholar
• Kang YH, Min HG, Kim IJ, et al. Comparison of alanine aminotransferase, white blood cell count, and uric acid in their association with metabolic syndrome: a study of Korean adults. Endocr J 2008;55:1093–102
   PubMed Web of Science ®Google Scholar
• Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 2002;51:3391–9
   PubMed Web of Science ®Google Scholar
• Dandona P, Aljada A, Mohanty P, et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 2001;86:3257–65
   PubMed Web of Science ®Google Scholar
• Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004;25:4–7
   PubMed Web of Science ®Google Scholar
• Dandona P, Aljada A, Chaudhuri A, Mohanty P. Endothelial dysfunction, inflammation and diabetes. Rev Endocr Metab Disord 2004;5:189–97
   PubMed Web of Science ®Google Scholar
• Tong PC, Lee KF, So WY, et al. White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes. Diabetes Care 2004;27:216–22
   PubMed Web of Science ®Google Scholar
• Ryan SM, Waack BJ, Weno BL, Heistad DD. Increases in pulse pressure impair acetylcholine-induced vascular relaxation. Am J Physiol 1995;268:H359–63
   Google Scholar
• Hensley K, Robinson KA, Gabbita SP, et al. Reactive oxygen species, cell signaling, and cell injury. Redox Biol 2000;28:1456–62
   Google Scholar
• Abramson JL, Weintraub WS, Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension 2002;39:197–202
   PubMed Web of Science ®Google Scholar
• Orakzai RH, Orakzai SH, Nasir K, et al. Association of white blood cell count with systolic blood pressure within the normotensive range. J Hum Hypertens 2006;20:341–7
   Google Scholar
• Gillum RF, Mussolino ME. White blood cell count and hypertension incidence. The NHANES I Epidemiologic Follow-up Study. J Clin Epidemiol 1994;47:911–19
   Google Scholar
• Shankar A, Mitchell P, Rochtchina E, Wang JJ. The association between circulating white blood cell count, triglyceride level and cardiovascular and all-cause mortality: population-based cohort study. Atherosclerosis 2007;192:177–83
   Google Scholar